Abel F - Search Results

1

Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K. Karlsson E, et al. Among authors: abel f. BMC Cancer. 2008 Sep 8;8:254. doi: 10.1186/1471-2407-8-254. BMC Cancer. 2008. PMID: 18778486 Free PMC article.

2

No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p.

Bergman A, Abel F, Behboudi A, Yhr M, Mattsson J, Svensson JH, Karlsson P, Nordling M. Bergman A, et al. Among authors: abel f. BMC Med Genet. 2008 Dec 13;9:108. doi: 10.1186/1471-2350-9-108. BMC Med Genet. 2008. PMID: 19077293 Free PMC article.

3

ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.

Wilzén A, Krona C, Sveinbjörnsson B, Kristiansson E, Dalevi D, Øra I, De Preter K, Stallings RL, Maris J, Versteeg R, Nilsson S, Kogner P, Abel F. Wilzén A, et al. Among authors: abel f. Mol Cancer. 2013 Jul 8;12(1):70. doi: 10.1186/1476-4598-12-70. Mol Cancer. 2013. PMID: 23835063 Free PMC article.

4

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.

Abel F, Ejeskär K, Kogner P, Martinsson T. Abel F, et al. Br J Cancer. 1999 Dec;81(8):1402-9. doi: 10.1038/sj.bjc.6692231. Br J Cancer. 1999. PMID: 10604740 Free PMC article.

5

Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.

Abel F, Sjöberg RM, Ejeskär K, Krona C, Martinsson T. Abel F, et al. Br J Cancer. 2002 Feb 12;86(4):596-604. doi: 10.1038/sj.bjc.6600111. Br J Cancer. 2002. PMID: 11870543 Free PMC article.

6

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Krona C, Ejeskär K, Carén H, Abel F, Sjöberg RM, Martinsson T. Krona C, et al. Among authors: abel f. Br J Cancer. 2004 Sep 13;91(6):1119-30. doi: 10.1038/sj.bjc.6602083. Br J Cancer. 2004. PMID: 15328517 Free PMC article.

7

High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.

Carén H, Abel F, Kogner P, Martinsson T. Carén H, et al. Among authors: abel f. Biochem J. 2008 Dec 1;416(2):153-9. doi: 10.1042/bj20081834. Biochem J. 2008. PMID: 18990089

8

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes.

Thorell K, Bergman A, Carén H, Nilsson S, Kogner P, Martinsson T, Abel F. Thorell K, et al. Among authors: abel f. BMC Med Genomics. 2009 Aug 17;2:53. doi: 10.1186/1755-8794-2-53. BMC Med Genomics. 2009. PMID: 19686582 Free PMC article.

9

A 6-gene signature identifies four molecular subgroups of neuroblastoma.

Abel F, Dalevi D, Nethander M, Jörnsten R, De Preter K, Vermeulen J, Stallings R, Kogner P, Maris J, Nilsson S. Abel F, et al. Cancer Cell Int. 2011 Apr 14;11:9. doi: 10.1186/1475-2867-11-9. Cancer Cell Int. 2011. PMID: 21492432 Free PMC article.

10

The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.

Wilzén A, Nilsson S, Sjöberg RM, Kogner P, Martinsson T, Abel F. Wilzén A, et al. Among authors: abel f. Int J Oncol. 2009 Mar;34(3):697-705. doi: 10.3892/ijo_00000196. Int J Oncol. 2009. PMID: 19212675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters